FDA Approved: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Jubilant Cadista Pharmaceuticals' supplemental application for nitrofurantoin (monohydrate/macrocrystals).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Nitrofurantoin (monohydrate/macrocrystals) (Nitrofurantoin monohydrate/macrocystals)

Snippet

SUPPL AP for NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) (NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS))